Islet Amyloid Development in a Mouse Strain Lacking Endogenous Islet Amyloid Polypeptide (IAPP) but Expressing Human IAPP

Molecular Medicine

Volumn 6, Issue 12, 2000, Pages 998-1007

  Westermark, Gunilla T ^a   Gebre Medhin, Samuel ^b   Steiner, Donald F ^d   Westermark, Per ^c  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

Amyloid Development; hIAPP Transgenic Mice; Human IAPP; Islet Amyloid Polypeptide (IAPP); Transgenic Mouse Strain

Indexed keywords

AMYLIN; AMYLOID;

AMYLOIDOSIS; ANIMAL; ARTICLE; BIOSYNTHESIS; BODY WEIGHT; CROSS BREEDING; DOSE RESPONSE; ENVIRONMENT; FAT INTAKE; FEMALE; GENETICS; HOMOZYGOTE; HUMAN; KINETICS; MALE; METABOLISM; MOUSE; PANCREAS; PANCREAS ISLET; PATHOLOGY; SEX DIFFERENCE; TIME; TRANSGENIC MOUSE;

AMYLOID; AMYLOIDOSIS; ANIMALS; BODY WEIGHT; CROSSES, GENETIC; DIETARY FATS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENT; FEMALE; HOMOZYGOTE; HUMANS; ISLETS OF LANGERHANS; KINETICS; MALE; MICE; MICE, TRANSGENIC; PANCREAS; SEX FACTORS; TIME FACTORS;

MLCS; MLOWN;

EID: 0034570847     PISSN: 10761551     EISSN: 15283658     Source Type: Journal    
DOI: 10.1007/BF03402051     Document Type: Article

References (33)

1. P. Westermark K.H. Johnson T.D. O’Brien C. Betsholtz Islet amyloid polypeptide a novel controversy in diabetes research Diabetologia 1992 35 297 303 10.1007/BF00401195 1:CAS:528:DyaK38XkvVOltLc%3D 1516756
2. O. Schmitz B. Nyholm C.B. Juhl S. Lund L. Ørskov Aspects on secretion and actions of amylin: interplay between amylin and other hormones J. Endocrin. Invest. 1999 22 suppl 5 33 36 1:STN:280:DyaK1MzmvFWksA%3D%3D
3. P. Westermark C. Wernstedt E. Wilander K. Sletten A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas Biochem. Biophys. Res. Commun. 1986 140 827 831 10.1016/0006-291X(86)90708-4 1:CAS:528:DyaL2sXnvVyqtA%3D%3D 3535798
4. P. Westermark Islet pathology of non-insulin-dependent diabetes mellitus (NIDDM) Diabet. Med. 1996 13 S46 48 8894481 1:STN:280:DyaK2s%2FkvFOmsQ%3D%3D
5. S.E. Kahn S. Andrikopoulos C.B. Verchere Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes Diabetes 1999 48 241 253 10.2337/diabetes.48.2.241 1:CAS:528:DyaK1MXpsFKguw%3D%3D 10334297
6. J. Janson R.H. Ashley D. Harrison S. McIntyre P.C. Butler The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles Diabetes 1999 48 491 498 10.2337/diabetes.48.3.491 1:CAS:528:DyaK1MXhsFymsbk%3D 10078548
7. C. Betsholtz V. Svensson F. Rorsman et al. Islet amyloid polypeptide (IAPP): cDNA cloning and identification of an amyloidogenic region associated with the species-specific occurrence of age-related diabetes mellitus Exp. Cell Res. 1989 183 484 493 10.1016/0014-4827(89)90407-2 1:CAS:528:DyaK3cXitlSmt7s%3D 2670595
8. P. Westermark U. Engström K.H. Johnson G.T. Westermark C. Betsholtz Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation Proc. Natl. Acad. Sci. U.S.A. 1990 87 5036 5040 10.1073/pnas.87.13.5036 1:CAS:528:DyaK3cXkslWnsL0%3D 2195544 54256
9. D.A. D’Alessio C.B. Verchere S.E. Kahn et al. Pancreatic expression and secretion of human islet amyloid polypeptide in a transgenic mouse Diabetes 1994 43 1457 1461 10.2337/diab.43.12.1457 7958499
10. E.J. de Koning J.W. Höppener C. Oosterwijk et al. Localisation of islet amyloid polypeptide (IAPP) in pancreatic islets of transgenic mice expressing the human or rat IAPP gene Biochem. Soc. Trans. 1993 21 26S 10.1042/bst021026s 8449306
11. N. Fox J. Schrementi M. Nishi et al. Human islet amyloid polypeptide transgenic mice as a model of non-insulin-dependent diabetes mellitus (NIDDM) FEBS Lett. 1993 323 40 44 10.1016/0014-5793(93)81444-5 1:CAS:528:DyaK3sXksVKksL0%3D 8495745
12. K. Yagui T. Yamaguchi A. Kanatsuka et al. Formation of islet amyloid fibrils in beta-secretory granules of transgenic mice expressing human islet amyloid polypeptide/amylin Eur. J. Endocrinol. 1995 132 487 496 10.1530/eje.0.1320487 1:CAS:528:DyaK2MXkvVyruro%3D 7711888
13. C.B. Verchere D.A. D’Alessio R.D. Palmiter et al. Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide Proc. Natl. Acad. Sci. U.S.A. 1996 93 3492 3496 10.1073/pnas.93.8.3492 1:CAS:528:DyaK28XisVWit7c%3D 8622964 39637
14. W.C. Soeller J. Janson S.E. Hart et al. Islet amyloid-associated diabetes in obese A(vy)/a mice expressing human islet amyloid polypeptide Diabetes 1998 47 743 750 10.2337/diabetes.47.5.743 1:CAS:528:DyaK1cXjs1SgsLg%3D 9588445
15. J. Janson W.C. Soeller P.C. Roche et al. Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide Proc. Natl. Acad. Sci. U.S.A. 1999 93 7283 7288 10.1073/pnas.93.14.7283
16. J.W.M. Höppener C. Oosterwijk M.G. Nieuwenhuis et al. Extensive islet amyloid formation is induced by development of type 2 diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model Diabetologia 1999 42 427 434 10.1007/s001250051175 10230646
17. G. Westermark M.B. Arora N. Fox et al. Amyloid formation in response to beta cell stress occurs in vitro, but not in vivo, in islets of transgenic mice expressing human islet amyloid polypeptide Mol. Med. 1995 1 542 553 10.1007/BF03401591 1:CAS:528:DyaK2MXns1Srur8%3D 8529120 2229964
18. E.J. de Koning E.R. Morris F.M. Hofhuis et al. Intra- and extracellular amyloid fibrils are formed in cultured pancreatic islets of transgenic mice expressing human islet amyloid polypeptide Proc. Natl. Acad. Sci. U.S.A. 1994 91 8467 8471 10.1073/pnas.91.18.8467 8078905 44627
19. D.L.A. MacArthur E.J.P. de Koning J.S. Verbeek J.F. Morris A. Clark Amyloid fibril formation is progressive and correlates with beta-cell secretion in transgenic mouse isolated islets Diabetologia 1999 42 1219 1227 10.1007/s001250051295 1:CAS:528:DyaK1MXmt1ymt7w%3D 10525663
20. P. Westermark Z.C. Li G.T. Westermark A. Leckström D.F. Steiner Effects of beta cell granule components on human islet amyloid polypeptide fibril formation FEBS. Lett. 1996 379 203 206 10.1016/0014-5793(95)01512-4 1:CAS:528:DyaK28Xht1Wltb4%3D 8603689
21. S. Janciauskiene S. Eriksson E. Carlemalm B. Ahrén B cell granule peptides affect human islet amyloid polypeptide (IAPP) fibril formation in vitro Biochem. Biophys. Res. Commun. 1997 236 580 585 10.1006/bbrc.1997.7014 1:CAS:528:DyaK2sXltVGqtrw%3D 9245692
22. S. Gebre-Medhin H. Mulder M. Pekny et al. Increased insulin secretion and glucose tolerance in mice lacking islet amyloid polypeptide (amylin) Biochem. Biophys. Res. Commun. 1998 250 271 277 10.1006/bbrc.1998.9308 1:CAS:528:DyaK1cXmt1yns7g%3D 9753619
23. G.T. Westermark A. Leckström Z. Ma P. Westermark Increased release of IAPP in response to long-term high fat intake in mice Horm. Metab. Res. 1998 30 256 258 10.1055/s-2007-978878 1:CAS:528:DyaK1cXjs1GgsLs%3D 9660084
24. G.T. Westermark K.H. Johnson P. Westermark Staining methods for identification of amyloid in tissue Meth. Enzymol. 1999 309 3 25 10.1016/S0076-6879(99)09003-5 1:CAS:528:DC%2BD3cXksVKisA%3D%3D 10507013
25. Z. Ma G.T. Westermark K.H. Johnson T.D. O’Brien P. Westermark Quantitative immunohistochemical analysis of islet amyloid polypeptide (IAPP) in normal, impaired glucose tolerant, and diabetic cats Amyloid 1998 5 255 261 10.3109/13506129809007298 1:CAS:528:DyaK1MXhtlSgsb8%3D 10036583
26. H. LeVine III Quantification of β-sheet amyloid fibrils structures with thioflavin T Meth. Enzymol. 1999 309 274 284 10.1016/S0076-6879(99)09020-5 1:CAS:528:DC%2BD3cXksVKhuw%3D%3D 10507030
27. T. Wisniewski B. Frangione Apolipoprotein E a pathological chaperone protein in patients with cerebral and systemic amyloid Neurosci. Lett. 1992 135 235 238 10.1016/0304-3940(92)90444-C 1:CAS:528:DyaK38XhsV2ntr8%3D 1625800
28. I.D. Young L. Ailles S. Narindrasorasak R. Tan R. Kisilevsky Localization of the basement membrane heparan sulfate proteoglycan in islet amyloid deposits in type II diabetes mellitus Arch. Pathol. Lab. Med. 1992 116 951 954 1524461 1:CAS:528:DyaK3sXpvFKrsQ%3D%3D
29. T.T. Ashburn P.T. Lansbury Interspecies sequence variation affects the kinetics and the thermodynamics of amyloid formation: peptide models of pancreatic amyloid J. Am. Chem. Soc. 1993 115 11012 11013 10.1021/ja00076a078 1:CAS:528:DyaK3sXmslWksL4%3D
30. P. Westermark D. Eizirik D.G. Pipeleers C. Hellerström A. Andersson Rapid deposition of amyloid in human islets transplanted into nude mice Diabetologia 1995 38 543 549 10.1007/BF00400722 1:CAS:528:DyaK2MXms12ktLs%3D 7489836
31. A. Clark S.B. Charge M.K. Badman E.J. de Koning Islet amyloid in type 2 (non-insulin-dependent) diabetes A.P.M.I.S. 1996 104 12 18 1:STN:280:DyaK287psVaksw%3D%3D
32. U. Arnelo J. Permert T.E. Adrian J. Larsson P. Westermark R.D. Reidelberger Chronic infusion of islet amyloid polypeptide causes anorexia in rats Am. J. Physiol. 1996 271 R1654 1659 8997366 1:CAS:528:DyaK2sXmt1Glsw%3D%3D
33. U. Arnelo J.E. Blevins J. Larsson et al. Effects of acute and chronic infusion of islet amyloid polypeptide on food intake in rats Scand. J. Gastroenterol. 1996 31 83 89 10.3109/00365529609031632 1:CAS:528:DyaK28XhtFyrtbY%3D 8927946